J. Goldman & Co’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.21M	Sell	97,772 -339,481	-78%	-$7.54M	0.1%	307
2025 Q4	$11.3M	Sell	437,253 -231,887	-35%	-$5.51M	0.44%	97
2025 Q3	$17.2M	Buy	669,140 +12,576	+2%	+$309K	0.65%	68
2025 Q2	$15.7M	Sell	656,564 -202,567	-24%	-$5.11M	0.49%	87
2025 Q1	$21.3M	Buy	859,131 +731,988	+576%	+$17.5M	0.76%	48
2024 Q4	$2.4M	Buy	+127,143	New	+$2.23M	0.08%	265
2023 Q3	–	Sell	-51,931	Closed	-$2.08M	–	508
2023 Q2	$2.08M	Buy	+51,931	New	+$2.15M	0.12%	206
2020 Q1	–	Sell	-40,325	Closed	-$1.83M	–	342
2019 Q4	$1.83M	Buy	+40,325	New	+$1.71M	0.18%	148
2019 Q3	–	Sell	-90,418	Closed	-$3.61M	–	372
2019 Q2	$3.93M	Buy	+90,418	New	+$3.84M	0.45%	113
2018 Q3	–	Sell	-35,895	Closed	-$1.15M	–	383
2018 Q2	$1.15M	Buy	+35,895	New	+$1.24M	0.1%	248
2017 Q4	–	Sell	-203,400	Closed	-$7.64M	–	441
2017 Q3	$7.64M	Buy	+203,400	New	+$8.18M	0.72%	78